Clinical pharmacokinetics of adefovir in human immunodeficiency virus type 1-infected patients.

The pharmacokinetics and bioavailability of adefovir [9-[2-(phosphonomethoxy)ethyl]adenine] were examined at two dose levels in three phase I/II studies in 28 human immunodeficiency type 1-infected patients. The concentrations of adefovir in serum following the intravenous infusion of 1.0 or 3.0 mg/...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Cundy, K C, Barditch-Crovo, P, Walker, R E, Collier, A C, Ebeling, D, Toole, J, Jaffe, H S
Format: Artigo
Jezik:Inglês
Izdano: 1995
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC162955/
https://ncbi.nlm.nih.gov/pubmed/8585716
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki